Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$498.29 - $574.41 $41,856 - $48,250
-84 Reduced 80.77%
20 $10,000
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $95,082 - $110,541
-187 Reduced 64.26%
104 $54,000
Q1 2023

May 12, 2023

BUY
$535.0 - $604.82 $51,360 - $58,062
96 Added 49.23%
291 $164,000
Q3 2022

Nov 10, 2022

BUY
$507.19 - $604.49 $4,564 - $5,440
9 Added 4.84%
195 $100,000
Q2 2022

Aug 11, 2022

BUY
$500.9 - $612.21 $77,138 - $94,280
154 Added 481.25%
186 $100,000
Q1 2022

May 12, 2022

BUY
$524.0 - $644.92 $16,768 - $20,637
32 New
32 $19,000
Q2 2021

Aug 13, 2021

SELL
$441.0 - $508.24 $198,450 - $228,708
-450 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$439.85 - $518.83 $995,820 - $1.17 Million
-2,264 Reduced 83.42%
450 $205,000
Q4 2020

Feb 12, 2021

BUY
$435.06 - $527.66 $1.18 Million - $1.43 Million
2,714 New
2,714 $1.26 Million
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $89,942 - $110,380
-250 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$257.51 - $295.55 $64,377 - $73,887
-250 Reduced 50.0%
250 $73,000
Q3 2018

Nov 16, 2018

BUY
$205.57 - $244.32 $102,785 - $122,160
500 New
500 $122,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Banco De Sabadell, S.A Portfolio

Follow Banco De Sabadell, S.A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.